Nektar Therapeutics
NKTR
NKTR
199 hedge funds and large institutions have $1.78B invested in Nektar Therapeutics in 2016 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 101 increasing their positions, 34 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
199
Holders Change
+5
Holders Change %
+2.58%
% of All Funds
4.98%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
37
Increased
101
Reduced
34
Closed
28
Calls
$8.73M
Puts
$7M
Net Calls
+$1.73M
Net Calls Change
+$3.03M
Top Buyers
Top Sellers
1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$63M |
2 |
![]()
Loomis, Sayles & Company
Boston,
Massachusetts
|
-$16.8M |
3 |
DFO
Duquesne Family Office
New York
|
-$9.83M |
4 |
PC
PointState Capital
New York
|
-$9.45M |
5 |
![]()
Fidelity Investments
Boston,
Massachusetts
|
-$9.37M |